Skip to content

    Allied Blenders

    ABDL
    Fast Moving Consumer Goods·6 Nov 2025
    Management Summary

    Allied Blenders delivered a strong Q2 FY26, marked by double-digit growth in revenue, EBITDA, and PAT, driven by premiumization and international expansion. The company successfully commissioned its PET bottle facility, enhancing margins and operational control. While Mass Premium faced headwinds from regulatory changes, the Prestige & Above segment continued its robust growth, and the company remains optimistic about market normalization and future growth initiatives.

    Highlights

    6
    • Strong financial performance with 14.4% YoY revenue growth to ₹995 crores.

    • Significant profitability improvement: EBITDA up 23.6% to ₹130 crores (13.1% margin) and PAT up 32.3% to ₹63 crores.

    • Robust volume growth of 8.4% YoY to 9 million cases, coupled with a 3.8% increase in realization per case.

    • Prestige & Above category showed strong momentum with 28.8% YoY volume growth, increasing its salience to 47.1%.

    • Successful commissioning of the PET bottle manufacturing facility, expected to add ₹30 crores+ to gross margins and improve supply chain efficiency.

    • International expansion is impressive, reaching 30 countries from 14 in 18 months, with a target of 35 countries by Q4 FY26 and 1 million cases in Africa by FY28.

    Concerns

    3
    • Mass Premium category witnessed 5% degrowth versus Q2 FY25, primarily due to regulatory intervention in southern states and the Maharashtra-made liquor policy.

    • Telangana market faced temporary pipeline impact and overdues, though expected to normalize by Q3 FY26.

    • Net debt increased by ₹127 crores to ₹893 crores as of September 30, 2025, primarily due to capex investments.

    What Changed1

    vs Q3 FY26

    Guidance items13 → 9 (-4)
    Key financials

    Metrics

    9

    Periods

    2

    Headline

    7
    • Consolidated Income from Operations
      ₹995 Cr
      YoY+14.4%
    • EBITDA
      ₹130 Cr
      YoY+23.6%
    • EBITDA Margin
      13.1%
    • PAT
      ₹63 Cr
      YoY+32.3%
    • Volume Sales
      9 Mn
      YoY+8.4%

    H1 FY26

    2
    • Operating Cash Flow
      ₹147 Cr
    • Average Cost of Borrowing
      8.2%

    Segment breakdown

    Mass Premium Category
    4.3% Volume Growth (Q2 vs Q1 FY26)-5% Volume Degrowth (vs Q2 FY25)
    Prestige & Above Category
    8.3% Volume Growth (Q2 vs Q1 FY26)28.8% Volume Growth (YoY)47.1% Salience39.7% Salience (Q2 FY25)
    List

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Capex

    ₹527 crores

    Debt

    Net ₹893 crores

    Cost 8.2%

    Liquidity

    Liquidity disclosed

    Operating cash flows of INR147 crores were generated in H1 FY '26 due to high profitability and working capital discipline.

    Guidance & targets

    9
    CategoryTargetPriority
    International Footprint
    Number of countries
    35
    High
    International Volume
    Africa market volume
    1 million cases
    High
    Segment Salience
    P&A segment contribution
    50%
    Medium
    Capex
    Single malt distillery operational
    Operational
    High
    Capex
    ENA distillation capacity operational
    Operational
    High
    Brand Performance
    ABDM Maestro revenue run rate
    ₹40 crores
    High
    A&P Spend
    A&P as % of P&A NSV
    4.5-5%
    High
    A&P Spend
    Increase in A&P investment
    75-100 bps YoY
    High
    Regulatory
    UK FTA import duty reduction
    Expected
    Medium

    Telangana market normalization

    Q3 FY26
    CurrentImpacted by licensing changes, pipeline correction underway
    TargetBusiness back to usual, pipeline correction complete

    Why it matters

    Normalization of this key market is crucial for Mass Premium volume recovery and overall sales.

    And from 1st December, this will be business back as usual. And the pipeline correction that has happened, we see significant part of the pipeline correction to correct itself in the month of December itself. So we are gearing up to meet that demand. Mostly, it will normalize in Q3. That is right.

    How to verify

    key_financials.segment_breakdown[name='Mass Premium Category'].metrics[label='Volume Degrowth (vs Q2 FY25)']

    Risks & concerns

    4
    RiskSeverity

    Regulatory intervention in southern states

    Caused 5% degrowth in Mass Premium category in Q2 FY26 vs Q2 FY25, with short-term pipeline impact.Management acknowledged

    medium

    Maharashtra-made liquor policy (MML)

    Impacted IMFL volumes by about 20% and overall Alcobev market; management is engaging with policymakers but needs more time to assess.Management acknowledged

    medium

    Telangana overdues

    Outstanding dues of ~₹700 crores (₹250-300 crores current, rest overdue), though ₹100 crores received in October 2025 and continuous reduction is expected.Management acknowledged

    medium

    State-level regulatory changes and rise of local brands

    Identified as a potential challenge in certain states, though regulatory reforms in other states like Andhra Pradesh are positive.Management acknowledged

    low

    Q&A highlights

    8

    “this investment will add roughly Rs. 30 crores plus to our gross margins, translating to about 75 basis points, let's say, on current year volume. So that's the impact on our gross margin and absolute EBITDA in terms of the contribution that this unit will make. Secondly, on economies of scale, we do not have any disadvantage on economies of scale because the PET manufacturing is not centralized unlike the glass bottle manufacturing. PET manufacturing is fairly decentralized. So we have enough scale because we are producing 600 million bottles at this facility.”

    Clarifies the direct financial benefit (margin improvement) and addresses concerns about scale disadvantage for in-house PET production.

    asked by Abneesh Roy

    3 min read7 chapters

    Detailed Narrative

    01

    Strong Q2 FY26 Financial Performance

    Allied Blenders reported a robust Q2 FY26, with consolidated income from operations reaching ₹995 crores, marking a 14.4% year-on-year increase. EBITDA grew by 23.6% to ₹130 crores, improving the margin to 13.1%. Profit after tax (PAT) saw a significant jump of 32.3% to ₹63 crores. Volume sales increased by 8.4% to 9 million cases, complemented by a 3.8% rise in realization per case, indicating effective product mix and pricing strategies.

    02

    Premiumization and Brand Momentum

    The company's premiumization strategy continues to yield results, with the Prestige & Above (P&A) segment demonstrating strong growth. P&A volumes grew 28.8% year-on-year, increasing its salience to 47.1% from 39.7% in Q2 FY25. ICONIQ White remains a standout performer, doubling its volume organically and expanding its international footprint to eight countries. Officer's Choice continues to lead the Mass Premium segment, maintaining over 40% gross margins and driving cash flow. The refreshed Sterling Reserve B7 campaign, 'So Smooth Must Be Magic,' is reversing degrowth trends in priority markets.

    03

    Strategic International Expansion

    Allied Blenders' international expansion has been impressive, growing its reach from 14 to 30 countries within 18 months, with a target of 35 countries by Q4 FY26. The company aims to achieve 1 million cases in the Africa market by FY28 and expects international revenue to contribute 12-15% of total value. ICONIQ White is now available in eight countries, and luxury brands like Arthaus and Zoya Gin have debuted in UAE duty-free markets, showcasing a high-margin export model with less working capital.

    04

    Backward Integration and Capex Program

    The company successfully commissioned its PET bottle manufacturing facility in Rangapur, Telangana, in September 2025, with a capital investment of ₹115 crores. This facility is expected to produce over 600 million PET bottles annually, adding over ₹30 crores to gross margins and enhancing supply chain efficiency. Other capex projects, including the single malt distillery at Rangapur and ENA distillation capacity expansion at Aurangabad, are on track for operationalization in Q4 FY26 and Q4 FY27, respectively. The overall capex program of ₹527 crores is phased, with 60% allocated for FY26 and 15% for FY27.

    05

    Financial Health and Capital Management

    Operating cash flows of ₹147 crores were generated in H1 FY26, reflecting strong profitability and working capital discipline. Net debt increased by ₹127 crores to ₹893 crores as of September 30, 2025, primarily due to capex. The average cost of borrowing reduced by 140 basis points to 8.2% in H1 FY26 from 9.6% in H1 FY25, supported by two credit rating upgrades. The company maintains its leverage ratios within stated guidelines, even during the peak capex phase.

    06

    Market Dynamics and Regulatory Landscape

    The Mass Premium segment experienced 5% degrowth in Q2 FY25 due to regulatory intervention in southern states, though normalization is expected by Q3 FY26. The Maharashtra-made liquor policy led to a 20% decline in IMFL volumes, with management awaiting further clarity. Telangana overdues saw some recovery, with ₹100 crores received in October 2025, and continuous reduction is anticipated. The industry benefits from stable raw material costs and regulatory reforms in states like Andhra Pradesh, supporting margin stability and volume recovery.

    07

    Luxury Portfolio and Future Outlook

    ABDM's luxury portfolio, including Zoya Gin and Arthaus, is expanding its presence in addressable markets and travel retail. The company plans to launch three new brands in H2 FY26 to complete its portfolio. The A&P spend is currently 4.5-5% of P&A NSV, with plans to increase it by 75-100 basis points year-on-year for the next 2-3 years. Management is optimistic about a positive outlook for H2 FY26, driven by the festive season and continued focus on profitable growth and sustainability.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.